Detalhe da pesquisa
1.
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Gynecol Oncol
; 186: 61-68, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603953
2.
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
Gynecol Oncol
; 178: 102-109, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839312
3.
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Gynecol Oncol
; 177: 38-45, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634258
4.
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Gynecol Oncol
; 178: 161-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890345
5.
Abdominopelvic MR to CT registration using a synthetic CT intermediate.
J Appl Clin Med Phys
; 23(9): e13731, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920116
6.
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.
Gynecol Oncol
; 160(3): 660-668, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423806
7.
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
Gynecol Oncol
; 162(3): 532-538, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217544
8.
Adjusting to the new reality: Evaluation of early practice pattern adaptations to the COVID-19 pandemic.
Gynecol Oncol
; 158(2): 256-261, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482336
9.
Sleep, quality of life, and depression in endometrial cancer survivors with obesity seeking weight loss.
Support Care Cancer
; 28(5): 2311-2319, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31478164
10.
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.
Gynecol Oncol
; 155(3): 420-428, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623857
11.
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 153(2): 335-342, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30827726
12.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Lancet
; 390(10103): 1654-1663, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756902
13.
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Gynecol Oncol
; 145(3): 519-525, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392124
14.
Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538].
Gynecol Oncol
; 163(3): 616-617, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654574
15.
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.
Gynecol Oncol
; 136(3): 529-33, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575483
16.
A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 138(1): 36-40, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25958319
17.
Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.
Gynecol Oncol
; 137(2): 239-44, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641568
18.
Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 138(3): 614-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26144601
19.
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.
Invest New Drugs
; 32(4): 729-38, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619298
20.
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.
J Clin Oncol
; : JCO2301279, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662968